Prostaglandins and sepsis: Still a fascinating topic despite almost 40 years of research

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 281, Issue 3 25-3, 2001, Pages

  Fink, Mitchell P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTAGLANDIN DERIVATIVE; PROSTANOID; TUMOR NECROSIS FACTOR;

HUMAN; MEDICAL RESEARCH; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEPSIS; SHORT SURVEY;

EID: 0034828821     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.281.3.l534     Document Type: Short Survey

References (46)

1. Ozone reduces murine alveolar and peritoneal macrophage phagocytosis: The role of prostanoids
2. The mechanism of inhibition of interleukin 2 production
3. Elevated thromboxane levels in the rat during endotoxic shock: Protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency
4. Basic biology and clinical application of specific cyclooxygenase-2 inhibitors
5. Prostaglandin endoperoxide synthase: Regulation of enzyme expression
6. Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes
7. Occupancy of platelet receptors for platelet-activating factor in patients with septicemia
8. Blockade of prostaglandin products augments macrophage and neutrophil tumor necrosis factor synthesis in burn injury
9. The complex pattern of cytokines in sepsis. Association between prostaglandins, cachectin, and interleukins
10. 2 modulation of superoxide production of human neutrophils
11. Inhibition of prestoglandin synthesis restores normal hemodynamics in canine hyperdynamic sepsis
12. 2 metabolism in endotoxic pigs: Effect of ibuprofen and meclofenamate
13. Tumor necrosis factor-induced mortality is reversed with cyclooxygenase inhibition
14. E. coli endotoxin shock in the dog; treatment with lidocaine or indomethacin
15. Indomethacin treatment following baboon endotoxin shock improves survival
16. Prostaglanditx E1 inhibits N-formyl-methionyl-leucyl-phenylalanine-mediated depolarization responses by decreasing the proportion of responsive cells without affecting chemotaxin-induced forward light scatter changes
17. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes
18. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro
19. Modulation of helper T cell function by prostaglandins
20. Regulation of the mRNA expression for tumor necrosis factor-alpha in rat liver macrophages
21. 2. Suppression of the generation of immunoglobulin secreting cells
22. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines
23. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors
24. Prostaglandin E2 regulates macrophage de tumor necrosis factor gene expression
25. Regulation of macrophage tumor necrosis factor production by prostaglandin E2
26. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs
27. Cyclooxygenase is an immediate-early gene induced by interleukin- 1 in human endothelial cells
28. Arachidonic acid oxygenation by COX-1 and COX-2
29. Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: The effect of antiinflammatory agents
30. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme
31. Analgesic-antipyretic drugs as antagonists of endotoxin shock in dogs
32. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase
33. Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase
34. Regulation of cyclooxygenase synthesis by interleukin-1
35. Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis
36. Nonsteroidal anti-inflammatory drugs increase tumor necrosis factor production in the periphery but not in the central nervous system in mice and rats
37. Cyclooxygenase-2 inhibitor NS-398 improves survival and restores leukocyte counts in burn infection
38. Differential sensitivity of in vivo TNF and IL-6 production to modulation by anti-inflammatory drugs in mice
39. Prostanoid biosynthesis and mechanisms of action
40. Prostaglandnis modulate macrophage Ia expression
41. Pretreatment with ibuprofen augments circulating tumor necrosis factor-alpha, interleukin-6, and elastase during acute endotoxemia
42. 2
43. 2 after trauma attenuates pro-inflammatory cytokines and improves survival
44. 2
45. Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro
46. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs